Theranostics · 2022 · 37 citations · 63 references
MedicineMolecular BiologyOncologyInflammationMolecular OncologyTumor MicroenvironmentCancer Cell SignalingCancer GenomicsCancer Stem CellsColorectal CancerInflammatory SignalingSignal Transduction In CancerCancer BioinformaticsCancer Stem Cell Signaling PathwaysCancer Stem-like CellsCyclooxygenase-2 PathwayInflammation-mediated CarcinogenesisInflammatory Microenvironment ModulationInflammatory NicheMalignant Progression
Rationale: Doublecortin-like kinase 1 (DCLK1) is a serine/threonine kinase that selectively marks cancer stem-like cells (CSCs) and promotes malignant progression in colorectal cancer (CRC). However, the exact molecular mechanism by which DCLK1 drives the aggressive phenotype of cancer cells is incompletely determined. Methods: Here, we performed comprehensive genomics and proteomics analyses to identify binding proteins of DCLK1 and discovered X-ray repair cross-complementing 5 (XRCC5). Thus, we explored the biological role and downstream events of the DCLK1/XRCC5 axis in human CRC cells and CRC mouse models.
63
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Glynn Dennis, Brad T. Sherman, Douglas A Hosack et al. · Genome biology · 2003 · 9.5K citations · Full text
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan et al. · Signal Transduction and Targeted Therapy · 2021 · 2.7K citations · Full text
Life Sciences, Immunology, Oncology +17
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Glynn Dennis, Brad T. Sherman, Douglas A Hosack et al. · Genome biology · 2003 · 2.4K citations · Full text
Victor Prima, Lyudmila N. Kaliberova, Sergey A. Kaliberov et al. · Proceedings of the National Academy of Sciences · 2017 · 491 citations · Full text
Life Sciences, Immunology, Oncology +17